Insider Buying: Johnson Matthey (LON:JMAT) Insider Buys 10 Shares of Stock

Johnson Matthey PLC (LON:JMATGet Free Report) insider Liam Condon purchased 10 shares of Johnson Matthey stock in a transaction that occurred on Wednesday, February 11th. The stock was acquired at an average cost of GBX 2,342 per share, with a total value of £234.20.

Liam Condon also recently made the following trade(s):

  • On Tuesday, January 13th, Liam Condon acquired 10 shares of Johnson Matthey stock. The shares were acquired at an average price of GBX 2,321 per share, for a total transaction of £232.10.
  • On Wednesday, December 10th, Liam Condon bought 14 shares of Johnson Matthey stock. The stock was acquired at an average cost of GBX 2,013 per share, for a total transaction of £281.82.

Johnson Matthey Stock Performance

Johnson Matthey stock opened at GBX 2,346 on Thursday. Johnson Matthey PLC has a 52 week low of GBX 1,131 and a 52 week high of GBX 2,434. The company has a current ratio of 1.45, a quick ratio of 0.76 and a debt-to-equity ratio of 62.73. The stock has a market cap of £3.93 billion, a P/E ratio of -35.60, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.95. The stock has a 50 day moving average of GBX 2,235.95 and a 200-day moving average of GBX 2,069.

Johnson Matthey (LON:JMATGet Free Report) last posted its quarterly earnings results on Thursday, November 20th. The company reported GBX 51.20 earnings per share (EPS) for the quarter. Johnson Matthey had a return on equity of 4.49% and a net margin of 0.84%. On average, analysts expect that Johnson Matthey PLC will post 173.4112903 EPS for the current fiscal year.

Analyst Ratings Changes

Several brokerages have recently issued reports on JMAT. Citigroup boosted their price target on shares of Johnson Matthey from GBX 1,800 to GBX 2,100 and gave the company a “neutral” rating in a report on Tuesday, October 21st. Deutsche Bank Aktiengesellschaft raised their price target on shares of Johnson Matthey from GBX 2,300 to GBX 2,400 and gave the company a “buy” rating in a research note on Wednesday, January 21st. Panmure Gordon reaffirmed a “buy” rating and set a GBX 2,370 price target on shares of Johnson Matthey in a report on Monday, November 24th. Finally, Berenberg Bank reduced their price objective on shares of Johnson Matthey from GBX 2,100 to GBX 2,050 and set a “hold” rating for the company in a report on Tuesday, November 25th. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of GBX 2,268.

Check Out Our Latest Analysis on JMAT

Johnson Matthey Company Profile

(Get Free Report)

Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.

Further Reading

Insider Buying and Selling by Quarter for Johnson Matthey (LON:JMAT)

Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.